Additional Resources

Societies/Websites

American College of Chest Physicians. http://www.chestnet.org
American Lung Association (ALA). Lung Helpline and Tobacco Quitline. Find multiple resources, including local expert care. https://www.lung.org/help-support/lung-helpline-and-tobacco-quitline
American Lung Association (ALA). Patient & Caregiver Network. Additional resources, webcasts, disease management tools. https://www.lung.org/help-support/patient-caregiver-network
Centers for Disease Control and Prevention (CDC). Asthma. Resources for Healthcare Professionals and Schools. Last reviewed February 27, 2023. https://www.cdc.gov/asthma/healthcare.html#guidelines
Centers for Disease Control and Prevention (CDC). Know How to Use Your Asthma Inhaler. Last reviewed December 12, 2022. https://www.cdc.gov/asthma/inhaler_video/default.htm
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2024 update). Updated July 2024. https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf.
Global Initiative for Asthma (GINA). Difficult-to-Treat & Severe Asthma in adolescent and adult patients. Diagnosis and Management. https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf
National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). https://www.nhlbi.nih.gov/science/national-asthma-education-and-prevention-program-naepp
National Environmental Education Foundation (NEEF). Environmental management of pediatric asthma. Guidelines for health care providers. https://www.neefusa.org/resource/environmental-management-pediatric-asthma-guidelines-health-care-providers
National Jewish Health. https://www.nationaljewish.org/conditions/asthma

Pediatric-Focused Articles

Bacharier LB, Jackson DJ. Biologics in the treatment of asthma in children and adolescents. J Allergy Clin Immunol. 2023;151(3):581-589.
Bacharier LB, Guilbert TW, Katelaris CH, et al. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study. J Allergy Clinical Immunol. 2024;12(4):948-P959
Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364:1005-1015.
Jackson DJ, Bacharier LB, Gergen PJ, et al. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet. 2022;13;400(10351):502-511.
Lanier B, Bridges T, Kulus M, et al. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. J Allergy Clin Immunol. 2009;124:1210-1216.
Lizzo JM, Goldin J, Cortes S. Pediatric Asthma. StatPearls [Internet]. Last updated 5/2024. https://www.ncbi.nlm.nih.gov/books/NBK551631/
Schepel IRM, Banzon TM, Phipatanakul W. Future of biologics in pediatric asthma: Optimizing response, early introduction, and equitable access to treatment. Ann Allergy Asthma Immunol. 2024;132(1):13-20.

Articles

Aljebab F, Choonara I, Conroy S. Systematic review of the toxicity of long-course oral corticosteroids in children. PLoS One. 2017;12:e0170259.
Bleeker E, Menzies-Gow A, Price D, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med. 2020; 201:276-293.
Bourdin A, Adcock I, Berger P, et al. How can we minimise the use of regular oral corticosteroids in asthma? Eur Respir Rev. 2020;29:190085.
Castro M, Corren J, Pavord I, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378:2486-2496.
Cataldo D, Louis R, Michils A, et al. Severe asthma: Oral corticosteroid alternatives and the need for optimal referral pathways. J Asthma. 2021;58:1-11.
Choo XN, Pavord I. Morbidity associated with oral corticosteroids in patients with severe asthma. 2016;71:302-304.
Chung L, Upham J, Bardin P, et al. Rational oral corticosteroid use in adult severe asthma: A narrative review. Respirology. 2020;25,161-172.
Corren J, Parnes J, Wang L, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377:936-946.
Fuhlbrigge A, Sharma S. Oral corticosteroid use in asthma: A wolf in sheep’s clothing. J Allergy Clin Immunol Pract. 2021;9:347-348.
Grant T, Croce E, Matsui E. Asthma and the social determinants of health. Ann All Asthma. 2022;128:5-11.
Lefebvre P, Duh MS, Lafeuille MH, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136:1488-1495.
Manson S, Brown R, Cerulli A, et al. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med. 2009;103:975e994.
McBrien C, Menzies-Gow A. Time to FOCUS on oral corticosteroid stewardship in asthma management (Commentary). Respirology. 2019;24:304-305.
Menzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384:1800-1809.
Nair P, Wenzel S, Rabe K, et al. Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl J Med. 2017;376:2448-2458.
Price D, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: Long-term observational study. J Asthma Allergy. 2018;11:193-204.
Price D, Castro M, Bourdin A, et al. Short-course systemic corticosteroids in asthma: Striking the balance between efficacy and safety. Eur Respir Rev. 2020;29:190151.
Rabe K, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378:2475-2485.
Ramsahai JM, Hansbro P, Wark P. Mechanisms and management of asthma exacerbations. Am J Respir Crit Care Med. 2019;199:423-432.
Rowe B, Kirkland S, Vandermeer B, et al. Prioritizing systemic corticosteroid treatments to mitigate relapse in adults with acute asthma: A systematic review and network meta-analysis. Acad Emerg Med. 2017;24:371-381.
Tran T, MacLachlan S, Hicks W, et al. Oral corticosteroid treatment patterns of patients in the United States with persistent asthma. J Allerg Clin Immunol Pract. 2021;9:338-346.
Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: Population based cohort study. BMJ. 2017;357:j1415.